Sodium Phosphates (Fresenius Kabi USA, LLC)
Welcome to the PulseAid listing for the Sodium Phosphates drug offered from Fresenius Kabi USA, LLC. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Fresenius Kabi USA, LLC |
NON-PROPRIETARY NAME: | SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE |
SUBSTANCE NAME: | SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; SODIUM PHOSPHATE, DIBASIC, ANHYDROUS |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | UNAPPROVED DRUG OTHER |
START MARKETING DATE: | 2000-09-06 |
END MARKETING DATE: | 0000-00-00 |
Sodium Phosphates HUMAN PRESCRIPTION DRUG Details:
Item Description | Sodium Phosphates from Fresenius Kabi USA, LLC |
LABELER NAME: | Fresenius Kabi USA, LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 276; 142(mg/mL; mg/mL) |
START MARKETING DATE: | 2000-09-06 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 63323-170_4bd4e702-5560-4abb-a142-b06940698cb2 |
PRODUCT NDC: | 63323-170 |
APPLICATION NUMBER: | |
Other SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; SODIUM PHOSPHATE, DIBASIC, ANHYDROUS Pharmaceutical Manufacturers / Labelers: